Springer Nature is monitoring the coronavirus situation closely. As a global company operating from multiple countries, remote working is something we are incredibly used to. Colleagues across all our teams remain accessible to you for any questions you may have. During this time, we are also doing everything necessary to make sure our research platforms remain fully available and we are ready to support the increasing numbers of researchers, students and faculty working from remote locations. We want to make sure access to our content is not interrupted in any way.
There are many ways you can enable remote access for your users, and many institutions already have such mechanisms in place (i.e. proxy, VPN, federated access, etc.). Springer Nature is here to support you with remote access for your patrons. We understand that organizations have different preferences and systems to enable this and we try to facilitate your preferred way of working. If there is anything we can do to assist you in securing remote access for your users please feel free to contact us at email@example.com.
To make remote access easier we will soon keep users logged in for 90 days after their initial authentication. We will keep the 90-day period under review and will update you of any change. In parallel, we are exploring new methods of access and will be piloting Google Scholar Universal CASA for remote access across multiple devices.
If you haven’t done so already now might be the time to set up federated access:
Springer Nature knows how essential access to research is in slowing the spread of COVID-19. We have made available for free all relevant research we have published and continue to publish, and are strongly urging our authors submitting articles related to this emergency to share underlying datasets relating to the outbreak as rapidly and widely as possible.
We continue to work with global organisations to support the sharing of relevant research and data and are a signatory on the Wellcome Trust consensus statement, Sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak, as well as supporting the initiative from the White House Office of Science and Technology to make all relevant global research, and data, available in one place. We also have a role to play providing good, fact-based journalistic and opinion content on this fast-moving public health issues in Nature (for researchers and research leaders) and Scientific American (for the broader public).
In these difficult times, we remain focused on providing you with the excellent service and support you expect from us. Colleagues across all our teams remain accessible to you for any questions you may have.